Top Markets
#1 Nesa Nesa +819.45%
#2 Cortex Cortex +68.87%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.70%
#4 QuantixAI QuantixAI +24.05%
#5 EXOD EXOD +22.78%
#6 OpenEden OpenEden +20.21%
#7 Palladium Network Palladium Network +18.98%
#8 Cash Cat Cash Cat +17.14%
#9 Instadapp Instadapp +16.92%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +15.48%
Coin of the day
Nesa Nesa
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Abcam plc Abcam plc

Abcam plc

ABCM
Peringkat dalam Saham #3678
Abcam plc operates as a prominent life science enterprise, dedicated to the... Abcam plc operates as a prominent life science enterprise, dedicated to the innovation, creation, and supply of crucial reagents and instruments. These fundamental resources are instrumental in supporting diverse scientific investigations, diagnostic applications, and the advancement of pharmaceutical drug discovery initiatives. Its comprehensive product portfolio features primary and secondary antibodies, conjugated antibodies paired with their respective kits, both singleplex and multiplex immunoassays, as well as a variety of proteins and peptides, including cytokines. Furthermore, the company provides edited cell lines, lysates, cellular activity kits, miRNA kits, biochemical compounds, and specialized tools for analyzing cell signaling pathways. Abcam serves a broad customer base, encompassing researchers and scientists within academic and institutional environments, alongside professionals at pharmaceutical, biotechnology, and diagnostic companies. The company boasts a global presence, conducting operations across the Americas, Europe, the Middle East, Africa, China, Japan, and the wider Asia Pacific region. Product distribution is primarily facilitated via its online platform. Founded in 1998, Abcam plc is headquartered in Cambridge, United Kingdom.
Harga Saham
$23.99
Terakhir disinkronkan: 2023-12-15
Kapitalisasi Pasar
$4.90B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan Abcam plc (ABCM)

Kategori

Healthcare
Laba untuk Abcam plc (ABCM)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Abcam plc, laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Abcam plc dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH